MENU
ELVN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Enliven Therapeutics (ELVN) Earnings Date & Reports
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics... Show more
A.I. Advisor
published Earnings
ELVN is expected to report earnings to fall 9.65% to -44 cents per share on November 18
Q3'26
Est.
$-0.44
Q2'26
Missed
by $0.10
Q1'26
Beat
by $0.06
Q4'25
Missed
by $0.02
Q3'25
Beat
by $0.18
The last earnings report on August 05 showed earnings per share of -49 cents, missing the estimate of -39 cents. With 715.60K shares outstanding, the current market capitalization sits at 3.37B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
6200 Lookout Road
Phone
+1 720 647-8519
Employees
60
Web
https://www.enliventherapeutics.com